vs

Side-by-side financial comparison of Fulgent Genetics, Inc. (FLGT) and Northfield Bancorp, Inc. (NFBK). Click either name above to swap in a different company.

Fulgent Genetics, Inc. is the larger business by last-quarter revenue ($71.1M vs $41.3M, roughly 1.7× Northfield Bancorp, Inc.). On growth, Northfield Bancorp, Inc. posted the faster year-over-year revenue change (12.7% vs -3.2%). Over the past eight quarters, Northfield Bancorp, Inc.'s revenue compounded faster (15.0% CAGR vs 0.1%).

Fulgent Genetics, Inc. is a molecular diagnostics technology firm that develops and offers genetic testing services including carrier screening, oncology testing, infectious disease detection, and hereditary condition analysis, serving clinical providers, pharma firms, research institutions and public health groups primarily in North America.

Northfield Bancorp, Inc. is a regional bank holding company based in the United States, operating primarily across the U.S. Northeast region. It provides a full range of personal and commercial banking services including deposit accounts, mortgage loans, commercial lending, and wealth management solutions for retail consumers, small to medium-sized businesses and local community clients.

FLGT vs NFBK — Head-to-Head

Bigger by revenue
FLGT
FLGT
1.7× larger
FLGT
$71.1M
$41.3M
NFBK
Growing faster (revenue YoY)
NFBK
NFBK
+15.8% gap
NFBK
12.7%
-3.2%
FLGT
Faster 2-yr revenue CAGR
NFBK
NFBK
Annualised
NFBK
15.0%
0.1%
FLGT

Income Statement — Q1 FY2026 vs Q4 FY2025

Metric
FLGT
FLGT
NFBK
NFBK
Revenue
$71.1M
$41.3M
Net Profit
$-27.4M
Gross Margin
30.2%
Operating Margin
21.1%
-1263.3%
Net Margin
-1545.5%
Revenue YoY
-3.2%
12.7%
Net Profit YoY
-343.6%
EPS (diluted)
$0.04
$-0.68

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
FLGT
FLGT
NFBK
NFBK
Q1 26
$71.1M
Q4 25
$83.3M
$41.3M
Q3 25
$84.1M
$39.2M
Q2 25
$81.8M
$38.9M
Q1 25
$73.5M
$34.8M
Q4 24
$76.2M
$36.7M
Q3 24
$71.7M
$31.8M
Q2 24
$71.0M
$31.5M
Net Profit
FLGT
FLGT
NFBK
NFBK
Q1 26
Q4 25
$-23.4M
$-27.4M
Q3 25
$-6.6M
$10.8M
Q2 25
$-19.0M
$9.6M
Q1 25
$-11.5M
$7.9M
Q4 24
$-5.9M
$11.3M
Q3 24
$-14.6M
$6.5M
Q2 24
$-8.7M
$6.0M
Gross Margin
FLGT
FLGT
NFBK
NFBK
Q1 26
30.2%
Q4 25
39.1%
Q3 25
42.2%
Q2 25
42.1%
Q1 25
38.6%
Q4 24
41.8%
Q3 24
37.3%
Q2 24
37.3%
Operating Margin
FLGT
FLGT
NFBK
NFBK
Q1 26
21.1%
Q4 25
-43.5%
-1263.3%
Q3 25
-18.3%
37.7%
Q2 25
-24.1%
35.6%
Q1 25
-26.9%
31.0%
Q4 24
-21.2%
38.0%
Q3 24
-23.8%
27.9%
Q2 24
-26.6%
29.1%
Net Margin
FLGT
FLGT
NFBK
NFBK
Q1 26
Q4 25
-28.1%
-1545.5%
Q3 25
-7.9%
27.4%
Q2 25
-23.2%
24.6%
Q1 25
-15.7%
22.6%
Q4 24
-7.7%
30.7%
Q3 24
-20.4%
20.5%
Q2 24
-12.3%
18.9%
EPS (diluted)
FLGT
FLGT
NFBK
NFBK
Q1 26
$0.04
Q4 25
$-0.68
Q3 25
$0.27
Q2 25
$0.24
Q1 25
$0.19
Q4 24
$0.27
Q3 24
$0.16
Q2 24
$0.14

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
FLGT
FLGT
NFBK
NFBK
Cash + ST InvestmentsLiquidity on hand
$23.4M
$164.0M
Total DebtLower is stronger
Stockholders' EquityBook value
$690.1M
Total Assets
$1.2B
$5.8B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
FLGT
FLGT
NFBK
NFBK
Q1 26
$23.4M
Q4 25
$50.2M
$164.0M
Q3 25
$117.6M
$131.7M
Q2 25
$87.9M
$97.6M
Q1 25
$67.3M
$101.7M
Q4 24
$55.1M
$167.7M
Q3 24
$58.0M
$232.9M
Q2 24
$65.1M
$153.5M
Total Debt
FLGT
FLGT
NFBK
NFBK
Q1 26
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
$666.4M
Q3 24
Q2 24
Stockholders' Equity
FLGT
FLGT
NFBK
NFBK
Q1 26
Q4 25
$1.1B
$690.1M
Q3 25
$1.1B
$719.6M
Q2 25
$1.1B
$710.3M
Q1 25
$1.1B
$711.1M
Q4 24
$1.1B
$704.7M
Q3 24
$1.1B
$699.6M
Q2 24
$1.1B
$693.0M
Total Assets
FLGT
FLGT
NFBK
NFBK
Q1 26
$1.2B
Q4 25
$1.2B
$5.8B
Q3 25
$1.2B
$5.7B
Q2 25
$1.2B
$5.7B
Q1 25
$1.2B
$5.7B
Q4 24
$1.2B
$5.7B
Q3 24
$1.2B
$5.7B
Q2 24
$1.2B
$5.7B
Debt / Equity
FLGT
FLGT
NFBK
NFBK
Q1 26
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
0.95×
Q3 24
Q2 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
FLGT
FLGT
NFBK
NFBK
Operating Cash FlowLast quarter
$53.7M
Free Cash FlowOCF − Capex
$52.5M
FCF MarginFCF / Revenue
127.1%
Capex IntensityCapex / Revenue
2.8%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$89.2M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
FLGT
FLGT
NFBK
NFBK
Q1 26
Q4 25
$-78.1M
$53.7M
Q3 25
$11.1M
$13.9M
Q2 25
$-30.2M
$14.1M
Q1 25
$-4.4M
$9.4M
Q4 24
$25.0M
$31.1M
Q3 24
$-15.5M
$14.0M
Q2 24
$4.3M
$6.9M
Free Cash Flow
FLGT
FLGT
NFBK
NFBK
Q1 26
Q4 25
$-83.1M
$52.5M
Q3 25
$5.1M
$13.6M
Q2 25
$-37.0M
$13.9M
Q1 25
$-9.1M
$9.2M
Q4 24
$21.2M
$30.0M
Q3 24
$-35.0M
$13.7M
Q2 24
$-8.7M
$6.7M
FCF Margin
FLGT
FLGT
NFBK
NFBK
Q1 26
Q4 25
-99.7%
127.1%
Q3 25
6.0%
34.6%
Q2 25
-45.2%
35.7%
Q1 25
-12.5%
26.3%
Q4 24
27.9%
81.6%
Q3 24
-48.8%
43.2%
Q2 24
-12.2%
21.1%
Capex Intensity
FLGT
FLGT
NFBK
NFBK
Q1 26
Q4 25
6.0%
2.8%
Q3 25
7.2%
0.8%
Q2 25
8.3%
0.6%
Q1 25
6.4%
0.7%
Q4 24
5.0%
3.1%
Q3 24
27.2%
0.7%
Q2 24
18.2%
0.8%
Cash Conversion
FLGT
FLGT
NFBK
NFBK
Q1 26
Q4 25
Q3 25
1.29×
Q2 25
1.48×
Q1 25
1.20×
Q4 24
2.76×
Q3 24
2.14×
Q2 24
1.16×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons